XML 14 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Note 6 - Investments in and Advances to Unconsolidated Joint Ventures
3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Equity Method Investments and Joint Ventures Disclosure [Text Block]

6. Investments in and Advances to Unconsolidated Joint Ventures

 

As of  March 31, 2020 and December 31, 2019, the Company had ownership interests in 10 unconsolidated joint ventures with ownership percentages that generally ranged from 5% to 35%. The condensed combined balance sheets for our unconsolidated joint ventures accounted for under the equity method were as follows:

 

   

March 31,

   

December 31,

 
   

2020

   

2019

 
   

(Dollars in thousands)

 

Cash and cash equivalents

  $ 30,514     $ 31,484  

Restricted cash

    13,237       13,852  

Real estate inventories

    234,460       241,416  

Other assets

    4,108       3,843  

Total assets

  $ 282,319     $ 290,595  
                 

Accounts payable and accrued liabilities

  $ 16,570     $ 16,778  

Notes payable

    21,910       28,665  

Total liabilities

    38,480       45,443  

The New Home Company's equity(1)

    28,403       27,722  

Other partners' equity

    215,436       217,430  

Total equity

    243,839       245,152  

Total liabilities and equity

  $ 282,319     $ 290,595  
Debt-to-capitalization ratio     8.2 %     10.5 %
Debt-to-equity ratio     9.0 %     11.7 %

 


(1)

Balance represents the Company's interest, as reflected in the financial records of the respective joint ventures. This balance differs from the investment in and advances to unconsolidated joint ventures balance reflected in the Company's consolidated balance sheets by$0.8 million due an other-than-temporary impairment charge to the Company's investment, interest capitalized to the Company's investment in joint ventures and certain other differences in outside basis.

 

The condensed combined statements of operations for our unconsolidated joint ventures accounted for under the equity method were as follows:

 

   

Three Months Ended March 31,

 
   

2020

   

2019

 
   

(Dollars in thousands)

 

Revenues

  $ 31,647     $ 42,287  

Cost of sales and expenses

    30,285       41,774  

Net income of unconsolidated joint ventures

  $ 1,362     $ 513  

Equity in net income (loss) of unconsolidated joint ventures reflected in the accompanying condensed consolidated statements of operations

  $ (1,937 )   $ 184  

 

 

The Company reviews its investments in and advances to unconsolidated joint ventures for other-than-temporary declines in value in accordance with ASC  820 . To the extent we deem any declines in value of our investment in and advances to unconsolidated joint ventures to be other-than-temporary, we impair our investment accordingly. For the three months ended March 31, 2020 and 2019, the Company recorded other-than-temporary, noncash impairment charges of $2.3 million and $0, respectively.  The 2020 impairment charge related to our investment in the Arantine Hills Holdings LP ("Bedford") joint venture and is included in equity in net income (loss) of unconsolidated joint ventures in the accompanying condensed consolidated statements of operations.  The Company has agreed in principle to sell our interest in this joint venture to our partner, and we are currently in the process of drafting definitive agreements associated with our exit from the joint venture and the sale of our interest for less than our current carrying value. This transaction is expected to close around the end of the 2020 second quarter.  We are expected to receive $5.1 million in cash for our anticipated sale of our partnership interest and expect to have an option to purchase at market 30% of the lots from the masterplan community owned by the joint venture.

 

As a smaller reporting company, the Company is subject to the provisions of Rule 8-03(b)(3) of Regulation S-X which requires the disclosure of certain financial information for equity investees that constitute 20% or more of the Company's consolidated net income (loss).  For the three months ended March 31, 2019, no profit or loss allocations from the Company's unconsolidated joint ventures accounted for under the equity method exceeded 20% of the Company's consolidated net loss.  For the three months ended March 31, 2020, the loss allocation from one of the Company's unconsolidated joint ventures accounted for under the equity method exceeded 20% of the Company's consolidated net loss. The table below presents financial information for this joint venture for the three months ended March 31, 2020 and 2019:

 

   

Three Months Ended March 31,

 
   

2020

   

2019

 
   

(Dollars in thousands)

 

Revenues

  $ 4,624     $ 3,698  

Cost of land sales

    3,065       3,375  

Gross margin

  $ 1,559     $ 323  

Expenses

    674       636  

Net income (loss)

  $ 885     $ (313 )

Equity in net loss of unconsolidated joint ventures reflected in the accompanying condensed consolidated statements of operations

  $ (2,226 )   $ (30 )

 

In the above table, the Company's $2.2 million loss included in equity in net income (loss) of unconsolidated joint ventures for the three months ended March 31, 2020 includes a $2.3 million other-than-temporary impairment charge related to its interest in this joint venture.

 

For the three months ended March 31, 2020 and 2019, the Company earned $0.4 million and $0.5 million respectively, in management fees from its unconsolidated joint ventures. For additional detail regarding management fees, please see Note 12.